Form 4 Filing for Equillium, Inc. - Pruzanski Mark

Mark Pruzanski, a director at Equillium, Inc., was granted 70,000 stock options on May 28, 2026. These options, with an exercise price of $2.84, are for the company's Common Stock and will vest in twelve equal monthly installments starting from the grant date. However, the options will be fully vested by the date of the Issuer's annual meeting of stockholders following the grant date. The options have an expiration date of May 27, 2036. This transaction is reported on Form 4, indicating a change in ownership. The filing also notes that Pruzanski acquired these options under a direct ownership nature.